Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,958,535 papers from all fields of science
Search
Sign In
Create Free Account
Subutex
Known as:
Schering Plough Brand of Buprenorphine Hydrochloride
, Grünenthal Brand of Buprenorphine Hydrochloride
, Buprenorphine Grünenthal Brand
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Buprenex
Buprenorphine 8 MG Sublingual Tablet [Subutex]
Buprenorphine Sublingual Tablet [Subutex]
Subutex Pill
Broader (2)
Buprenorphine
Buprenorphine hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Risk Prediction in Cardiovascular Medicine Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease
D. Morrow
2010
Corpus ID: 21820596
The American Heart Association estimates that 1 in 3 American adults have cardiovascular (CV) disease, including 16.8 million…
Expand
2010
2010
Preventing progression of allergic rhinitis: the role of specific immunotherapy
A. Fiocchi
,
A. Fox
Archives of Disease in Childhood: Education…
2010
Corpus ID: 12630923
Allergic rhinitis and asthma are examples of allergic airways disease. Despite their differing symptomatology, both disorders…
Expand
Review
2007
Review
2007
AN-2690, a novel antifungal for the topical treatment of onychomycosis.
Orr G. Barak
,
D. S. Loo
Current opinion in investigational drugs
2007
Corpus ID: 13246250
Schering-Plough Corp, under license from Anacor Pharmaceuticals Inc, is developing AN-2690, an antifungal agent with activity…
Expand
2001
2001
Evaluation of a topical solution containing 65% permethrin against the sandfly (Phlebotomus perniciosus) in dogs.
R. Molina
,
J. Lohse
,
J. Nieto
Veterinary therapeutics : research in applied…
2001
Corpus ID: 37495091
A topical solution containing 65% permethrin (EXspot, Schering-Plough Animal Health Corp., Union, NJ) was evaluated for…
Expand
1997
1997
The antiandrogen withdrawal syndrome in relapsed prostate cancer.
H. Scher
,
G. Kolvenbag
European Urology
1997
Corpus ID: 40461645
Evolving data suggest that palliation of relapsed prostate cancer can be achieved by the selective discontinuation of agents that…
Expand
1997
1997
Effects of Brand Name Exposure on Brand Choices: an Implicit Memory Perspective
S. Chung
,
Katrin F. Szymanski
1997
Corpus ID: 142740385
1992
1992
Analysis of buprenorphine in urine specimens.
L. Debrabandere
,
M. Van Boven
,
P. Daenens
Journal of Forensic Sciences
1992
Corpus ID: 32326061
The simultaneous determination of buprenorphine (Temgesic) and its major metabolite, N-desalkylbuprenorphine, in urine samples…
Expand
1991
1991
[3H]SCH39166, a D1 dopamine receptor antagonist: Binding characteristics and localization
J. Wamsley
,
M. Hunt
,
R. Mcquade
,
M. Alburges
Experimental Neurology
1991
Corpus ID: 21400432
1983
1983
[A case of secondary buprenorphine (Temgesic) dependence].
J. Benos
Der Nervenarzt
1983
Corpus ID: 21325227
1976
1976
Topical Pharmacology of Imidazole Antifungals
R. Holt
Journal of cutaneous pathology
1976
Corpus ID: 21175458
Four imidazole derivatives have now undergone extensive open and comparative trials as topical agents in dermatomycoses and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE